Effect of the formulation parameters on the characteristics of pellets

Drug Development and Industrial Pharmacy

Volumn 24, Issue 11, 1998, Pages 1073-1076

  Fekete, R ^a   Zelko R ^a   Marton, S ^a   Racz I ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOSE; MICROCRYSTALLINE CELLULOSE; SALICYLIC ACID; STARCH;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG COATING; DRUG GRANULATION; DRUG PELLET; PARTICLE SIZE; PELLET EXTRUSION; PHYSICAL CHEMISTRY; SPHERONIZATION; TABLET FORMULATION;

EID: 0031711463     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049809089951     Document Type: Article

References (10)

1. R. Bodmeier, Eur. J. Pharm. Biopharm., 43, 1 (1997).
2. I. Rácz, Drug Formulation, John Wiley and Sons, New York, 1989, p. 362.
3. J. J. Sousa, A. Sousa, F. Podczek, and J. M. Newton, Int. J. Pharm., 144, 159 (1996).
4. N. Follonier and E. Doelker, S.T.P. Pharma Sci., 2, 141 (1992).
5. S. Marton, E. Bihari, Á. Orbán, D. Greskovits, and I. Rácz, in Proceedings of the 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, APGI/APV, Châtenay Malabry-Mainz, 1995, p. 357.
6. J. M. Newton, S.T.P. Pharma Sci., 6, 396 (1990).
7. D. Sonaglio, B. Bataille, C. Ortigosa, and M. Jacob, Int. J. Pharm., 115, 53 (1995).
8. L. Hasznos, T. Langer, and M. Gyarmathy, Drug Dev. Ind. Pharm., 18, 409 (1992).
9. R. M. Franz, J. E. Browne, and A. R. Lewis, in Pharmaceutical Dosage Forms. Disperse Systems (H. A. Lieberman, M. M. Rieger, and G. S. Banker, eds.), Marcel Dekker, New York, 1988, p. 427.
10. P. Holm, Pharm. Tech. Eur., 8, 38 (1996).